MGMT and glioblastoma: Corroborating an impact of α-syn in the reversal of a pharmacological resistance to TMZ, we show that α-syn overexpression in U87 resistant cells trigger a down-regulation of MGMT, a key prognostic marker of GBM response to TMZ, and that it restores TMZ ability to reduce GBM cells proliferation.